Figdor CG - Search Results

1

PLGA Nanoparticles Co-encapsulating NY-ESO-1 Peptides and IMM60 Induce Robust CD8 and CD4 T Cell and B Cell Responses.

Dölen Y, Gileadi U, Chen JL, Valente M, Creemers JHA, Van Dinther EAW, van Riessen NK, Jäger E, Hruby M, Cerundolo V, Diken M, Figdor CG, de Vries IJM. Dölen Y, et al. Among authors: figdor cg. Front Immunol. 2021 Feb 25;12:641703. doi: 10.3389/fimmu.2021.641703. eCollection 2021. Front Immunol. 2021. PMID: 33717196 Free PMC article.

2

The renal cell carcinoma-associated antigen G250 encodes a human leukocyte antigen (HLA)-A2.1-restricted epitope recognized by cytotoxic T lymphocytes.

Vissers JL, De Vries IJ, Schreurs MW, Engelen LP, Oosterwijk E, Figdor CG, Adema GJ. Vissers JL, et al. Among authors: figdor cg. Cancer Res. 1999 Nov 1;59(21):5554-9. Cancer Res. 1999. PMID: 10554034

3

[Immunology in medical practice. XXV. Use of dendritic cells in the immunotherapy of cancer].

Punt CJ, de Vries IJ, Mulders PF, Adema GJ, Figdor CG. Punt CJ, et al. Among authors: figdor cg. Ned Tijdschr Geneeskd. 1999 Nov 27;143(48):2408-14. Ned Tijdschr Geneeskd. 1999. PMID: 10608974 Review. Dutch.

4

Renal cell carcinoma-associated antigen G250 encodes a naturally processed epitope presented by human leukocyte antigen-DR molecules to CD4(+) T lymphocytes.

Vissers JL, De Vries IJ, Engelen LP, Scharenborg NM, Molkenboer J, Figdor CG, Oosterwijk E, Adema GJ. Vissers JL, et al. Among authors: figdor cg. Int J Cancer. 2002 Aug 1;100(4):441-4. doi: 10.1002/ijc.10518. Int J Cancer. 2002. PMID: 12115527 Free article.

5

Phenotypical and functional characterization of clinical grade dendritic cells.

de Vries IJ, Eggert AA, Scharenborg NM, Vissers JL, Lesterhuis WJ, Boerman OC, Punt CJ, Adema GJ, Figdor CG. de Vries IJ, et al. Among authors: figdor cg. J Immunother. 2002 Sep-Oct;25(5):429-38. doi: 10.1097/00002371-200209000-00007. J Immunother. 2002. PMID: 12218781

6

Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state.

De Vries IJ, Krooshoop DJ, Scharenborg NM, Lesterhuis WJ, Diepstra JH, Van Muijen GN, Strijk SP, Ruers TJ, Boerman OC, Oyen WJ, Adema GJ, Punt CJ, Figdor CG. De Vries IJ, et al. Among authors: figdor cg. Cancer Res. 2003 Jan 1;63(1):12-7. Cancer Res. 2003. PMID: 12517769

7

Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients.

de Vries IJ, Lesterhuis WJ, Scharenborg NM, Engelen LP, Ruiter DJ, Gerritsen MJ, Croockewit S, Britten CM, Torensma R, Adema GJ, Figdor CG, Punt CJ. de Vries IJ, et al. Among authors: figdor cg. Clin Cancer Res. 2003 Nov 1;9(14):5091-100. Clin Cancer Res. 2003. PMID: 14613986

8

Dendritic cell immunotherapy: mapping the way.

Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ. Figdor CG, et al. Nat Med. 2004 May;10(5):475-80. doi: 10.1038/nm1039. Nat Med. 2004. PMID: 15122249 Review.

9

Phenotypical and functional characterization of clinical-grade dendritic cells.

de Vries IJ, Adema GJ, Punt CJ, Figdor CG. de Vries IJ, et al. Among authors: figdor cg. Methods Mol Med. 2005;109:113-26. doi: 10.1385/1-59259-862-5:113. Methods Mol Med. 2005. PMID: 15585917 Review.

10

Migration of dendritic cell based cancer vaccines: in vivo veritas?

Adema GJ, de Vries IJ, Punt CJ, Figdor CG. Adema GJ, et al. Among authors: figdor cg. Curr Opin Immunol. 2005 Apr;17(2):170-4. doi: 10.1016/j.coi.2005.01.004. Curr Opin Immunol. 2005. PMID: 15766677 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

477 results

Search Page